US Patent Issued to THE CYPRUS FOUNDATION FOR MUSCULAR DYSTROPHY RESEARCH on March 24 for "AAV vectors with myelin protein zero promoter and uses thereof for treating SCHWANN cell-associated diseases like CHARCOT-MARIE-TOOTH disease" (Cypriot Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,725, issued on March 24, was assigned to THE CYPRUS FOUNDATION FOR MUSCULAR DYSTROPHY RESEARCH (Nicosia, Cyprus).

"AAV vectors with myelin protein zero promoter and uses thereof for treating SCHWANN cell-associated diseases like CHARCOT-MARIE-TOOTH disease" was invented by Kleopas Kleopa (Nicosia, Cyprus), Alexia Kagiava (Nicosia, Cyprus), Natasa Schiza (Nicosia, Cyprus) and Irene Sargiannidou (Nicosia, Cyprus).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides viral vectors for use in the treatment and prevention of diseases associated with Schwann cells by delivering polynucleotides specifically to Schwann cells and achi...